ST Premium

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!

FDMT Company Profile and Key Details

NASDAQ : FDMT

4D Molecular Therapeutics, Inc.

$3.92

0.17+4.53%

At Close 4:00 PM

60.74

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

FDMT Stock Price Chart

Stock Price Today

4D Molecular Therapeutics, Inc. (FDMT) stock surged +4.53%, trading at $3.92 on NASDAQ, up from the previous close of $3.75. The stock opened at $3.68, fluctuating between $3.58 and $3.94 in the recent session.

Stock Snapshot

3.75

Prev. Close

3.68

Open

181.51M

Market Cap

46.3M

Number of Shares

3.58

Day Low

3.94

Day High

-1.32

P/E Ratio

85.6%

Free Float in %

-2.98

EPS (TTM)

0.01

Book Value

Cash Flow per Share

1.3M

Volume

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Mar 21, 2025	3.68	3.94	3.58	3.92	1.29M
Mar 20, 2025	3.74	3.85	3.67	3.75	645.94K
Mar 19, 2025	3.86	3.88	3.66	3.79	672.93K
Mar 18, 2025	4.15	4.19	3.78	3.82	604.87K
Mar 17, 2025	4.12	4.21	3.90	4.18	644.53K
Mar 14, 2025	4.44	4.44	4.10	4.11	310.61K
Mar 13, 2025	4.24	4.40	4.17	4.28	447.87K
Mar 12, 2025	4.11	4.40	4.02	4.24	769.91K
Mar 11, 2025	3.93	4.17	3.73	4.11	793.4K
Mar 10, 2025	4.10	4.21	3.84	3.90	829.28K
Mar 07, 2025	4.18	4.27	4.03	4.07	610K
Mar 06, 2025	4.08	4.28	4.07	4.14	1.17M
Mar 05, 2025	4.00	4.34	3.95	4.16	731.13K
Mar 04, 2025	4.11	4.14	3.92	3.97	1.01M
Mar 03, 2025	4.57	4.81	4.12	4.14	668.9K
Feb 28, 2025	4.45	4.64	4.20	4.53	1.23M
Feb 27, 2025	4.76	4.87	4.45	4.48	503.6K
Feb 26, 2025	4.54	4.82	4.51	4.80	570.9K
Feb 25, 2025	4.52	4.76	4.44	4.54	500.52K
Feb 24, 2025	4.74	4.82	4.51	4.52	462.23K

Contact Details

EmeryVille, CA 94608

United States

Website: https://www.4dmoleculartherapeutics.comContact: 510 505 2680

About Company

4D Molecular Therapeutics, Inc., a clinical-stage gene therapy company, develops product candidates using its adeno-associated viruses vectors. It develops a portfolio of gene therapy product candidates focuses in three therapeutic areas: ophthalmology, cardiology, and pulmonology. The company has three product candidates that are in clinical trials: 4D-125 that is in a Phase 1/2 clinical trial for the treatment of X-linked retinitis pigmentosa; 4D-110 that is in a Phase 1/2 clinical trial for the treatment of choroideremia; and 4D-310, which is in a Phase 1/2 clinical trial for the treatment of Fabry disease. Its two IND candidates are 4D-150 for the treatment of wet age-related macular degeneration and 4D-710 for the treatment of cystic fibrosis lung disease. 4D Molecular Therapeutics, Inc. has research and collaboration arrangements with uniQure; CRF; Roche; and CFF. The company was founded in 2013 and is headquartered in Emeryville, California.4D Molecular Therapeutics, Inc., a clinical-stage gene therapy company, develops product candidates using its adeno-associated viruses vectors. It develops a portfolio of gene therapy product candidates focuses in three therapeutic areas: ophthalmology, cardiology, and pulmonology. The company has three product candidates that are in clinical trials: 4D-125 that is in a Phase 1/2 clinical trial for the treatment of X-linked retinitis pigmentosa; 4D-110 that is in a Phase 1/2 clinical trial for the treatment of choroideremia; and 4D-310, which is in a Phase 1/2 clinical trial for the treatment of Fabry disease. Its two IND candidates are 4D-150 for the treatment of wet age-related macular degeneration and 4D-710 for the treatment of cystic fibrosis lung disease. 4D Molecular Therapeutics, Inc. has research and collaboration arrangements with uniQure; CRF; Roche; and CFF. The company was founded in 2013 and is headquartered in Emeryville, California.

Frequently Asked Questions

What is the current 4D Molecular Therapeutics, Inc. (FDMT) stock price?

4D Molecular Therapeutics, Inc. (NASDAQ: FDMT) stock price is $3.92 in the last trading session. During the trading session, FDMT stock reached the peak price of $3.94 while $3.58 was the lowest point it dropped to. The percentage change in FDMT stock occurred in the recent session was 4.53% while the dollar amount for the price change in FDMT stock was $0.17.

FDMT's industry and sector of operation?

The NASDAQ listed FDMT is part of Biotechnology industry that operates in the broader Healthcare sector. 4D Molecular Therapeutics, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of FDMT?

Dr. An Song Ph.D.
Chief Devel. Officer
Ms. Theresa Janke
Co-Founder & Chief of Staff
Dr. David H. Kirn M.D.
Co-Founder, Chief Executive Officer & Director
Dr. Robert S. Fishman
Chief Medical Officer & Therapeutic Area Head of Pulmonology
Mr. August J. Moretti Esq., J.D.
Chief Financial Officer
Dr. Fred Kamal Ph.D.
Pres & Chief Operating Officer
Dr. Raphael Schiffmann M.D.
Senior Vice President & Therapeutic Area Head of Cardiology
Dr. Robert Y. Kim M.B.A., M.D.
Chief Medical Officer
Dr. Fariborz Kamal Ph.D.
Pres & Chief Operating Officer
Dr. John F. Milligan Ph.D.
Executive Chairman
Mike Zanoni
Vice President of Investor Relations
Dr. Scott P. Bizily J.D., Ph.D.
Chief Legal & HR Officer and Corporation Sec.
Ms. Karen S. Carothers
Controller

How FDMT did perform over past 52-week?

FDMT's closing price is 9.5% higher than its 52-week low of $3.58 where as its distance from 52-week high of $36.25 is -89.19%.

How many employees does FDMT have?

Number of FDMT employees currently stands at 147.

Link for FDMT official website?

Official Website of FDMT is: https://www.4dmoleculartherapeutics.com

How do I contact FDMT?

FDMT could be contacted at phone 510 505 2680 and can also be accessed through its website. FDMT operates from 5858 Horton Street, EmeryVille, CA 94608, United States.

How many shares of FDMT are traded daily?

FDMT stock volume for the day was 1.3M shares. The average number of FDMT shares traded daily for last 3 months was 830.12K.

What is the market cap of FDMT currently?

The market value of FDMT currently stands at $181.51M with its latest stock price at $3.92 and 46.3M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

About

Home About Meet The Team Contact Us Privacy Policy Newsletter

Employees	147
Beta	2.82
Sales or Revenue	$20.72M
5Y Sales Change%	-0.531%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology